Eptinezumab in Participants With Episodic Cluster Headache
Public ClinicalTrials.gov record NCT04688775. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Interventional, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Delayed-Start Study to Evaluate the Efficacy and Safety of Eptinezumab in Patients With Episodic Cluster Headache
Study identification
- NCT ID
- NCT04688775
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- H. Lundbeck A/S
- Industry
- Enrollment
- 231 participants
Conditions and interventions
Conditions
Interventions
- Eptinezumab Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 22, 2020
- Primary completion
- Jun 13, 2023
- Completion
- Oct 4, 2023
- Last update posted
- Aug 8, 2024
2020 – 2023
United States locations
- U.S. sites
- 24
- U.S. states
- 18
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barrow Neurological Institute | Phoenix | Arizona | 85013 | — |
| Mayo Clinic in Arizona - Phoenix Campus | Phoenix | Arizona | 85054 | — |
| Keck School of Medicine of USC | Los Angeles | California | 90033 | — |
| Clinical Research Institute | Los Angeles | California | 90048 | — |
| Stanford Neurosciences Health Center | Palo Alto | California | 94304 | — |
| Neurology Colorado - Denver Advanced Neurological Evaluation and Treatment Center | Denver | Colorado | 80218 | — |
| Yale New Haven Hospital | New Haven | Connecticut | 06510-2483 | — |
| New England Institute for Neurology and Headache | Stamford | Connecticut | 06905 | — |
| Accel Research Sites - Tampa | Tampa | Florida | 33634 | — |
| Diamond Headache Clinic | Chicago | Illinois | 60642 | — |
| Michigan Headache and Neurological Institute | Ann Arbor | Michigan | 48104-5131 | — |
| Mayo Clinic - Rochester | Rochester | Minnesota | 55905 | — |
| The Headache Center Mississippi | Ridgeland | Mississippi | 39157 | — |
| Clinvest Research | Springfield | Missouri | 65810 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Dent Neurologic Institute - Amherst | Amherst | New York | 14226 | — |
| New York University School of Medicine | New York | New York | 10016 | — |
| Headache Wellness Center | Greensboro | North Carolina | 27405 | — |
| Cleveland Clinic - Neurological Institute | Cleveland | Ohio | 44195 | — |
| The Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | — |
| Hightower Clinical | Oklahoma City | Oklahoma | 73134 | — |
| Thomas Jefferson University Hospital - Center City Campus | Philadelphia | Pennsylvania | 19107 | — |
| Mischer Neuroscience Institute | Houston | Texas | 77030 | — |
| Froedtert and Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 96 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04688775, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 8, 2024 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04688775 live on ClinicalTrials.gov.